299 related articles for article (PubMed ID: 33662168)
1. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
Aron JL; Akbari O
Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
[TBL] [Abstract][Full Text] [Related]
3. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
[TBL] [Abstract][Full Text] [Related]
4. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
5. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.
Fan XL; Zeng QX; Li X; Li CL; Xu ZB; Deng XQ; Shi J; Chen D; Zheng SG; Fu QL
Stem Cell Res Ther; 2018 Jun; 9(1):170. PubMed ID: 29921316
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
8. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
9. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
10. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis.
Fu QL; Chow YY; Sun SJ; Zeng QX; Li HB; Shi JB; Sun YQ; Wen W; Tse HF; Lian Q; Xu G
Allergy; 2012 Oct; 67(10):1215-22. PubMed ID: 22882409
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis.
Liu XQ; Peng YQ; Huang LX; Li CG; Kuang PP; Chen DH; Wu ZC; He BX; Zhou ZR; Fu QL
Stem Cell Res Ther; 2023 Jul; 14(1):180. PubMed ID: 37488601
[TBL] [Abstract][Full Text] [Related]
13. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
Maazi H; Patel N; Sankaranarayanan I; Suzuki Y; Rigas D; Soroosh P; Freeman GJ; Sharpe AH; Akbari O
Immunity; 2015 Mar; 42(3):538-51. PubMed ID: 25769613
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
[TBL] [Abstract][Full Text] [Related]
15. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.
Paclik D; Stehle C; Lahmann A; Hutloff A; Romagnani C
Eur J Immunol; 2015 Oct; 45(10):2766-72. PubMed ID: 26249010
[TBL] [Abstract][Full Text] [Related]
16. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
[TBL] [Abstract][Full Text] [Related]
17. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
[TBL] [Abstract][Full Text] [Related]
18. Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
Nayar S; Pontarini E; Campos J; Berardicurti O; Smith CG; Asam S; Gardner DH; Colafrancesco S; Lucchesi D; Coleby R; Chung MM; Iannizzotto V; Hunter K; Bowman SJ; Carlesso G; Herbst R; McGettrick HM; Browning J; Buckley CD; Fisher BA; Bombardieri M; Barone F
Commun Biol; 2022 May; 5(1):413. PubMed ID: 35508704
[TBL] [Abstract][Full Text] [Related]
19. ICOS promotes group 2 innate lymphoid cell activation in lungs.
Kamachi F; Isshiki T; Harada N; Akiba H; Miyake S
Biochem Biophys Res Commun; 2015 Aug; 463(4):739-45. PubMed ID: 26049110
[TBL] [Abstract][Full Text] [Related]
20. ER-stressed MSC displayed more effective immunomodulation in RA CD4
Wei J; Ouyang X; Tang Y; Li H; Wang B; Ye Y; Jin M; Al Azab M; Li W; Li X
Mod Rheumatol; 2020 May; 30(3):509-516. PubMed ID: 31370727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
